Emmanuelle Clappier

10.9k total citations
46 papers, 1.7k citations indexed

About

Emmanuelle Clappier is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Emmanuelle Clappier has authored 46 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 23 papers in Public Health, Environmental and Occupational Health and 13 papers in Molecular Biology. Recurrent topics in Emmanuelle Clappier's work include Acute Lymphoblastic Leukemia research (22 papers), Acute Myeloid Leukemia Research (20 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Emmanuelle Clappier is often cited by papers focused on Acute Lymphoblastic Leukemia research (22 papers), Acute Myeloid Leukemia Research (20 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Emmanuelle Clappier collaborates with scholars based in France, United States and Czechia. Emmanuelle Clappier's co-authors include Jean Soulier, Hervé Dombret, François Sigaux, André Baruchel, Jean‐Michel Cayuela, Marı́a L. Toribio, Marina García-Peydró, Armelle Régnault, Mireia Castillo-Martín and Alberto Ambesi‐Impiombato and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Emmanuelle Clappier

42 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuelle Clappier France 20 807 785 712 290 238 46 1.7k
Paula Gameiro Portugal 14 1.1k 1.3× 726 0.9× 798 1.1× 229 0.8× 113 0.5× 29 1.8k
Violaine Havelange Belgium 17 678 0.8× 769 1.0× 468 0.7× 558 1.9× 525 2.2× 46 1.7k
Zuzana Zemanová Czechia 22 987 1.2× 744 0.9× 380 0.5× 307 1.1× 235 1.0× 139 1.7k
Roberta La Starza Italy 24 976 1.2× 796 1.0× 460 0.6× 170 0.6× 124 0.5× 91 1.8k
Y Hayashi Japan 26 1.2k 1.5× 926 1.2× 754 1.1× 321 1.1× 237 1.0× 47 2.3k
Sandrine Hayette France 22 1.1k 1.3× 672 0.9× 490 0.7× 367 1.3× 128 0.5× 75 1.8k
Philipp A. Greif Germany 19 696 0.9× 718 0.9× 227 0.3× 387 1.3× 215 0.9× 59 1.4k
Ya‐Zhen Qin China 23 1.5k 1.9× 503 0.6× 639 0.9× 305 1.1× 107 0.4× 153 1.9k
M Malec Sweden 5 1.6k 2.0× 722 0.9× 888 1.2× 173 0.6× 135 0.6× 7 2.1k
Dimitri Breems Netherlands 18 1.7k 2.1× 692 0.9× 497 0.7× 363 1.3× 104 0.4× 44 2.2k

Countries citing papers authored by Emmanuelle Clappier

Since Specialization
Citations

This map shows the geographic impact of Emmanuelle Clappier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuelle Clappier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuelle Clappier more than expected).

Fields of papers citing papers by Emmanuelle Clappier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuelle Clappier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuelle Clappier. The network helps show where Emmanuelle Clappier may publish in the future.

Co-authorship network of co-authors of Emmanuelle Clappier

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuelle Clappier. A scholar is included among the top collaborators of Emmanuelle Clappier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuelle Clappier. Emmanuelle Clappier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Lin‐Pierre, Emmanuelle Clappier, Matthieu Duchmann, et al.. (2025). Prognostic significance of monocytic-like phenotype in patients with AML treated with venetoclax and azacytidine. Blood Advances. 9(14). 3556–3565.
2.
Zhao, Lin‐Pierre, Vincent Jachiet, Olivier Kosmider, et al.. (2025). Very long-term remission with azacitidine in VEXAS syndrome. Haematologica. 110(6). 1432–1435. 1 indexed citations
3.
Bordenave, Jennifer, David Michonneau, Nicolas Vallet, et al.. (2024). Deciphering bone marrow engraftment after allogeneic stem cell transplantation in humans using single-cell analyses. Journal of Clinical Investigation. 134(20). 2 indexed citations
4.
Lengliné, Étienne, Florence Rabian, Marco Cerrano, et al.. (2024). Blinatumomab consolidation for adult B-cell acute lymphoblastic leukemia in first and second complete remission. Blood Advances. 8(10). 2405–2409. 2 indexed citations
5.
Passet, Marie, Rathana Kim, & Emmanuelle Clappier. (2024). Genetic subtypes of B-cell acute lymphoblastic leukemia in adults. Blood. 145(14). 1451–1463. 4 indexed citations
6.
Berrou, Jeannig, Emmanuelle Clappier, Jean‐Michel Cayuela, et al.. (2022). Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (BCR::ABL+) Acute Lymphoblastic Leukemia (ALL). Journal of Clinical Medicine. 11(22). 6761–6761. 4 indexed citations
7.
Cabannes‐Hamy, Aurélie, Éolia Brissot, Thibaut Leguay, et al.. (2022). High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL. Haematologica. 107(9). 2072–2080. 24 indexed citations
8.
Zhao, Lin‐Pierre, Emmanuelle Clappier, Marie Sébert, et al.. (2021). Genomic landscape of MDS/CMML associated with systemic inflammatory and autoimmune disease. Leukemia. 35(9). 2720–2724. 25 indexed citations
9.
Zhao, Lin‐Pierre, Nabih Maslah, Emmanuelle Verger, et al.. (2021). Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms. Blood. 138(21). 2142–2148. 20 indexed citations
10.
Kim, Rathana, Lin‐Pierre Zhao, Adèle de Masson, et al.. (2021). Clinical, pathological, and molecular features of myelodysplasia cutis. Blood. 139(8). 1251–1253. 19 indexed citations
11.
Duployez, Nicolas, Matthieu Duchmann, Laëtitia Largeaud, et al.. (2021). Prognostic Significance of DDX41 Germline Mutations in Intensively Treated AML Patients: An ALFA-Filo Study. Blood. 138(Supplement 1). 612–612.
12.
Passet, Marie, C. Lepelletier, Marie‐Dominique Vignon‐Pennamen, et al.. (2020). Next-Generation Sequencing in Myeloid Neoplasm-Associated Sweet’s Syndrome Demonstrates Clonal Relation between Malignant Cells and Skin-Infiltrating Neutrophils. Journal of Investigative Dermatology. 140(9). 1873–1876.e5. 24 indexed citations
13.
Sandmann, Sarah, Aniek O. de Graaf, Magnus Tobiasson, et al.. (2020). Multicenter Next-Generation Sequencing Studies between Theory and Practice. Journal of Molecular Diagnostics. 23(3). 347–357. 3 indexed citations
14.
Vicente, Carmen, Claire Schwab, Michaël Broux, et al.. (2015). Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia. Haematologica. 100(10). 1301–1310. 113 indexed citations
15.
Herranz, Daniel, Alberto Ambesi‐Impiombato, Teresa Palomero, et al.. (2014). A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. Nature Medicine. 20(10). 1130–1137. 303 indexed citations
16.
17.
Gerby, Bastien, Emmanuelle Clappier, Florence Armstrong, et al.. (2011). Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations. Leukemia. 25(8). 1249–1258. 50 indexed citations
18.
Zuna, Jan, Hélène Cavé, Cornelia Eckert, et al.. (2007). Childhood secondary ALL after ALL treatment. Leukemia. 21(7). 1431–1435. 18 indexed citations
19.
Su, Xinying, Harry A. Drabkin, Emmanuelle Clappier, et al.. (2006). Transforming potential of the T-cell acute lymphoblastic leukemia-associated homeobox genesHOXA13,TLX1, andTLX3. Genes Chromosomes and Cancer. 45(9). 846–855. 25 indexed citations
20.
Clappier, Emmanuelle, Wendy Cuccuini, J M Cayuela, et al.. (2005). Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias. Leukemia. 20(1). 82–86. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paula Gameiro Breakdown of academic impact, for papers by Violaine Havelange Breakdown of academic impact, for papers by Zuzana Zemanová Breakdown of academic impact, for papers by Roberta La Starza Breakdown of academic impact, for papers by Y Hayashi Breakdown of academic impact, for papers by Sandrine Hayette Breakdown of academic impact, for papers by Philipp A. Greif Breakdown of academic impact, for papers by Ya‐Zhen Qin Breakdown of academic impact, for papers by M Malec Breakdown of academic impact, for papers by Dimitri Breems
Rankless by CCL
2026